Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2017 07:30 ET | Source: Medeor Therapeutics

Medeor Therapeutics Receives FDA Clearance of IND Application and Special Protocol Assessment for Pivotal Clinical Study of MDR-101

Personalized cellular immunotherapy designed to prevent transplant kidney rejection and eliminate the need for chronic anti-rejection drugs Single Phase 3 study will evaluate functional immune...